MedPath

A Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents

Not Applicable
Conditions
Depression
Interventions
Behavioral: Preventive Intervention Program (PIP) for depression
Registration Number
NCT02593266
Lead Sponsor
University of Chile
Brief Summary

The overall aim of this pilot study is to evaluate the acceptability and feasibility of an adaptation of Beardslee's 'Preventive Intervention Program (PIP) for Depression' in Chilean families.

The PIP is a family intervention directed towards strengthening family functioning and enhancing resilience in children of depressed parents. It comprises several modules that work on psycho-education and skill development within the family nucleus.

A single-blind randomized controlled trial will be conducted with two arms, the intervention arm (n=32) which will receive a home-based PIP for depression, and the TAU arm (n=32).

Detailed Description

Being a child with depressed parents is associated with poor health and academic outcomes as well as having four times the likelihood of developing a mood disorder compared to children of non-depressed parents.

Objectives: To evaluate acceptability and feasibility of an adaptation of Beardslee's 'Preventive Intervention Program (PIP) for Depression' in Chilean families, and to measure the clinical effects of this intervention.

Participants: Parents with an episode of Depression in the past 3 months with at least one non-depressed child between the ages of 6-12.

Design: single-blind randomized controlled trial with two groups; the intervention group (n=32), which will receive a home-based PIP for depression, and the treatment-as-usual control group (n=32).

Results: Acceptability and feasibility will be measured by determining whether the trial was successfully conducted and well received by the families and preventionists. Recruitment and delivery of the intervention will be assessed as well as whether there was appropriate response and follow-up, and whether the objectives of the study were reached. Secondary outcomes will look at depressive symptoms, family function, psycho-education, parental competence, adaptive behavior and resilience in children.

Follow-up times: T = 0 baseline, T= 2 months (post-intervention), T=5 months, T=8 months, T=11 months.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Patients who are currently undergoing a depressive episode or have done so in the past 3 months.
Exclusion Criteria

For parents:

  • Alcohol or drug dependence or abuse as assessed by the MINI or being in treatment for substance use.
  • Psychosis, personality disorder, bipolar disorder or suicide ideation as assessed by the MINI.
  • Having a relationship crisis with current partner. Assessed by self-report or by having attended couple's therapy in the past month.
  • Attending family therapy.

For children:

  • Being outside the age range of 6-12 years at the time of recruitment.
  • Intellectual disability
  • Having depression as assessed by the MINI Kid
  • Being in treatment for a psychiatric disorder or having taken psychotropic medication in the last month.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupPreventive Intervention Program (PIP) for depressionweekly sessions of PIP for depression.
Primary Outcome Measures
NameTimeMethod
acceptability7 weeks

The acceptability of the intervention will be evaluated through qualitative questionnaires.

feasibility7 weeks

Feasibility will be assessed by looking at the number of families succesfully completing the study.

Secondary Outcome Measures
NameTimeMethod
Depressive symptoms in children11 months

scores on the depression scale CDI

Depressive symptoms in parents11 months

scores on the depression scale BDI

Parental competence11 months

scores on the E2P scale

Adaptive behaviour in children11 months

scores on the CBCL scale

resilience in children11 months

scores on the ERE scale

Family functioning11 months

scores on the FACES-II scale

Trial Locations

Locations (1)

Clinica psiquiatrica Universitaria

🇨🇱

Santiago de Chile, Chile

© Copyright 2025. All Rights Reserved by MedPath